Medmira Stock Net Asset

47M Stock  EUR 0.05  0  6.52%   
MedMira fundamentals help investors to digest information that contributes to MedMira's financial success or failures. It also enables traders to predict the movement of MedMira Stock. The fundamental analysis module provides a way to measure MedMira's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MedMira stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

MedMira Company Net Asset Analysis

MedMira's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Net Asset

 = 

Current Market Value

-

Current Liabilities

More About Net Asset | All Equity Analysis

Current MedMira Net Asset

    
  3.83 M  
Most of MedMira's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MedMira is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Competition

Based on the recorded statements, MedMira has a Net Asset of 3.83 M. This is much higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The net asset for all Germany stocks is notably lower than that of the firm.

MedMira Net Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MedMira's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MedMira could also be used in its relative valuation, which is a method of valuing MedMira by comparing valuation metrics of similar companies.
MedMira is currently under evaluation in net asset category among its peers.

MedMira Fundamentals

About MedMira Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze MedMira's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MedMira using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MedMira based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in MedMira Stock

MedMira financial ratios help investors to determine whether MedMira Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MedMira with respect to the benefits of owning MedMira security.